Pancreatic Disorders & Therapy

Pancreatic Disorders & Therapy
Open Access

ISSN: 2165-7092

+44 1478 350008

Pancreatic Disorders & Therapy : Citations & Metrics Report

Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.

Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

40 50 25 28 9 1 7 11 21 35 20 33 30 5

Research, Review articles and Editorials

1 0 2 3 7 1 5 5 16 17 17 25 26 5

Research communications, Review communications, Editorial communications, Case reports and Commentary

39 50 18 14 2 0 2 6 5 6 3 2 4 0

Conference proceedings

0 9 8 0 0 0 21 74 53 0 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

19 42 46 48 62 45 39 55 73 39 31 6 0 0
Journal total citations count 437
Journal impact factor 1.58
Journal 5 years impact factor 3.08
Journal cite score 3.74
Journal h-index 11
Journal h-index since 2019 9
Important citations (368)

commentary on ?acute pancreatitis as initial demonstration of drug- induced vasculitis?

ct- and mri-based assessment of body composition and pancreatic fibrosis reveals high incidence of clinically significant metabolic changes that affect the quality of life and treatment outcomes of patients with chronic pancreatitis and pancreatic cancer.

biomarkers for early diagnosis of pancreatic cancer.

the effect of erythropoietin to pulmonary injury and mast cells secondary to acute pancreatitis

commentary on ?acute pancreatitis as initial demonstration of drug- induced vasculitis?

the nature and function of immunogenic tumor proteins that characterize pancreatic and colorectal cancer: a review

epigenetics - role as biomarker in cancer diagnosis

osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis

an attempt to evaluate selected aspects of "bone-fat axis" function in healthy individuals and patients with pancreatic cancer.

ras-related nuclear protein ran3b gene is involved in hormone responses in the embryogenic callus of dimocarpus longan lour.

ran promotes the proliferation and migration ability of head and neck squamous cell carcinoma cells.

membrane orientation dynamics of lipid-modified small gtpases.

loss of tumor suppressor merlin results in aberrant activation of wnt/?-catenin signaling in cancer.

dlran3a is involved in hormone, light, and abiotic stress responses in embryogenic callus of dimocarpus longan lour.

ran gtpase is an independent prognostic marker in malignant melanoma which promotes tumour cell migration and invasion.

periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study.

knockdown of ran gtpase expression inhibits the proliferation and migration of breast cancer cells

functional blockade of small gtpase ran inhibits glioblastoma cell viability.

lin28a regulates stem-like properties of ovarian cancer cells by enriching ran and hsbp1 mrna and up-regulating its protein expression.

new developments in the early diagnosis of pancreatic cancer

Top